Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Found vs Framework

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Found logo

Found

8.3
★★★★4.2/5

Best for: mainstream telehealth GLP-1 access

Visit Found
VS
Framework logo

Framework

6.6
★★★☆☆3.3/5

Best for: aggressive $25/week pricing with a named 503B pharmacy partner

Visit Framework

Found and Framework are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Framework starts lower at $108.33/mo versus $169/mo, and Found edges ahead overall (8.3 vs 6.6 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

Found

flat price at every doseCompounded
$169$99/mo
Save 41% right now
semaglutide

$169/mo cash-pay on 12-month prepaid plan, medication+membership+coaching included; promo_price 99 = $99/mo WITH insurance (12-mo prepaid). Month-to-month: $199/mo insurance, $289/mo cash. Site-wide '$100 off today' checkout promo running.

flat price at every doseCompounded
$169$99/mo
Save 41% right now
tirzepatide

Same single Compounded GLP-1 Plan price as semaglutide — no per-drug split published (final drug/price assignment is quiz-gated); $169/mo cash 12-mo prepaid ($289/mo month-to-month cash), $99/mo insurance prepaid.

StartingCompounded · oral
$149/mo
orforglipron (foundayo)

'Starting cash price ~$149/mo' on /medication/foundayo comparison table; NEW offering since last verification.

StartingBrand-name
$650/mo
semaglutide (wegovy)

Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.

StartingBrand-name
$650/mo
tirzepatide (zepbound)

Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.

StartingBrand-name
$1100/mo
semaglutide (ozempic)

Homepage carousel 'Ozempic® $1100/mo' — unchanged from prior verification.

StartingBrand-name
$1100/mo
tirzepatide (mounjaro)

Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.

Framework

As low as $25/week (~$100/mo)Compounded
$108.33/mo
semaglutide

Framework prices per WEEK, not per month: 'GLP 1s For As Low as $25/Week'. Fifty-two weeks is $1,300 a year, so the calendar month is $108.33, not $100. '$0 membership fees.'

As low as $25/week (~$100/mo)Compounded
$108.33/mo
tirzepatide

Same per-week rate; Framework quotes one figure for semaglutide and tirzepatide alike.

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 500+ providers' prices on their own sites and email you when tracked prices move.

What’s included

Found

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Included

Framework

What the monthly price covers

Medication

Included

Provider visits

Not disclosed

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Included

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Found

8.3/10

Overall

Framework

6.6/10

Value25%

8.5A
vs
B
8.0

Effectiveness25%

9.0A
vs
B
6.0

User Experience15%

8.0A
vs
B
6.0

Trust & Safety15%

7.3A
vs
B
6.3

Accessibility10%

8.5A
vs
B
6.0

Support10%

7.5A
vs
B
6.4

Features & Coverage

FeatureFoundFramework
Starting Price$169/mo$108.33/mo
Features3 features5 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About Found

Personalized weight care platform with a self-pay membership model plus medication costs.

Read our full Found review →

About Framework

Framework is a personalized-plan GLP-1 telehealth platform offering compounded semaglutide and tirzepatide with doctor-guided treatment selection. Its standout detail is a named pharmacy partner, The Pharmacy Hub, operating on the FDA-registered 503B outsourcing pathway rather than the patient-specific 503A compounding most direct-to-consumer competitors use. Pricing starts as low as $25/week (roughly $100/mo) with no membership fees.

Read our full Framework review →

Pros & Cons

Found

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

Framework

What we like

  • Named 503B pharmacy partner (The Pharmacy Hub) disclosed — the FDA-registered outsourcing-facility pathway, distinct from 503A
  • Publishes the FDA compounded-medication disclaimer
  • $25/week pricing (~$100/mo) is among the most aggressive in the directory
  • $0 membership fees
  • Phone support published, toll-free (888) 412-0666
  • Personalized-plan positioning vs one-size-fits-all marketplaces

Watch-outs

  • LegitScript ID / certification not shown on the homepage
  • States-served list not disclosed
  • Medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed (no footer copyright)
  • Governing law / arbitration venue not stated
  • Refund / cancellation policy not detailed
  • Per-dose pricing tiers not shown (only the 'as low as $25/week' starting tier)

Our Verdict

Winner: Found

Found edges out Framework with a higher overall score of 8.3/10 and is particularly strong for mainstream telehealth GLP-1 access. Framework remains a solid alternative, especially if you're looking for aggressive $25/week pricing with a named 503B pharmacy partner.

Choose Found if…

You want mainstream telehealth GLP-1 access and a starting price around $169/mo.

Choose Framework if…

You want aggressive $25/week pricing with a named 503B pharmacy partner and a starting price around $108.33/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.1

RxSpan MD

Physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

8.0

Strut Health

Oral-lozenge compounded GLP-1 access

7.8

Yucca Health

Mainstream telehealth GLP-1 access

Found vs Framework: FAQ

Framework is cheaper. Its lowest ongoing monthly cash price is $108.33/mo, compared with $169/mo for Found. We compare standing (not first-month promo) prices so the figures reflect what you'd actually pay month to month.
Found scores higher overall at 8.3/10 versus 6.6/10, and is particularly strong for mainstream telehealth GLP-1 access. That said, Framework is a better fit if you want aggressive $25/week pricing with a named 503B pharmacy partner.
Found lists availability in 50 states, while Framework's state list is not publicly listed.
Found is an affiliate partner (we may earn a commission on sign-ups through our links); Framework is not. Either way, we rank providers editorially with the same scoring framework and disclose every partnership — being a partner does not buy a higher score.
For Semaglutide, Found is cheaper at $99/mo versus $108.33/mo at Framework.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring Found and Framework head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.